Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2026)

Camp4 Therapeutics recorded quarterly Equity Ratio of 0.29 in Q1 2026, down 27.63% quarter-over-quarter from 0.4 in Q4 2025, and down 64.33% year-over-year from 0.82 in Q1 2025.

Camp4 Therapeutics' Equity Ratio history runs 4 years deep, the most recent figure standing at 0.29 for Q1 2026.

  • In Q1 2026, Equity Ratio fell 64.33% year-over-year to 0.29; the TTM figure through Mar 2026 stood at 0.29 (down 64.33% YoY), while the FY2025 annual figure was 0.4, down 49.78% from the prior year.
  • Equity Ratio came in at 0.29 for Q1 2026 at Camp4 Therapeutics, down from 0.4 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.82 in Q1 2025 to a low of 7.44 in Q3 2024.
  • A 4-year average of 0.74 and a median of 0.54 in 2025 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio jumped 135.81% in 2024 and sank 64.33% in 2026, its largest moves.
  • Camp4 Therapeutics' Equity Ratio stood at 2.25 in 2023, then surged by 135.81% to 0.81 in 2024, then tumbled by 49.78% to 0.4 in 2025, then declined by 27.63% to 0.29 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.29, 0.4, and 0.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Camp4 Therapeutics 245.89 Mn 245.89 Mn - 0.29

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.29
Dec 31, 2025 0.40
Sep 30, 2025 0.68
Jun 30, 2025 0.78
Mar 31, 2025 0.82
Dec 31, 2024 0.81
Sep 30, 2024 -7.44
Dec 31, 2023 -2.25